For the quarter ending 2026-03-31, RTGN has $5,805 in assets. $2,563,889 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 180 | 14,774 | 92 | 839 |
| Equipment, net of accumulated depreciation of 307 and 251 at june 30, 2025 and december 31, 2024, respectively | - | - | - | 0 |
| Total current assets | 180 | 14,774 | 92 | 839 |
| Operating lease right-of-use asset | 3,630 | 4,272 | 4,914 | 5,554 |
| Security deposit | 1,995 | 1,995 | 1,995 | 1,995 |
| Total assets | 5,805 | 21,041 | 7,001 | 8,388 |
| Accounts payable and accrued liabilities | 1,189,520 | 1,084,763 | 1,037,632 | 1,016,685 |
| Due to related parties-Sanovas | 830,632 | 674,842 | 539,052 | 352,177 |
| Due to related parties-Related Party | 468,428 | 489,224 | 528,738 | 547,148 |
| Shareholders notes payable | 49,000 | 49,000 | 49,000 | 49,000 |
| Operating lease liability current portion | 2,860 | 2,860 | 988 | 988 |
| Accrued interest payable | 20,239 | 19,279 | 18,319 | 17,359 |
| Total current liabilities | 2,560,679 | 2,319,968 | 2,173,729 | 1,983,357 |
| Operating lease liability long term portion | 3,210 | 3,684 | 6,002 | 6,196 |
| Total liabilities | 2,563,889 | 2,323,652 | 2,179,731 | 1,989,553 |
| Common stock, 0.0001 par value 80,000,000 shares authorized 18,754,739 shares issued and outstanding at march 31, 2026 and december 31, 2025 | 1,875 | 1,875 | 1,860 | 1,856 |
| Additional paid-in capital | 15,889,147 | 15,679,131 | 15,060,900 | 14,683,678 |
| Stock subscription receivable | - | 125,000 | - | 0 |
| Accumulated deficit | -18,449,106 | -17,858,617 | -17,235,490 | -16,666,699 |
| Total stockholders deficit | -2,558,084 | -2,302,611 | -2,172,730 | -1,981,165 |
| Total liabilities and stockholders deficit | 5,805 | 21,041 | 7,001 | 8,388 |
RetinalGenix Technologies Inc. (RTGN)
RetinalGenix Technologies Inc. (RTGN)